There are two broad categories of ADHD medication types used in Australia: psychostimulants and non-psychostimulants. Understanding this distinction matters because it affects everything from how quickly a medication works to how it’s prescribed, to which one a doctor might reach for first depending on a person’s age, health history, and other conditions.
This guide covers the full range of ADHD medication types Australia currently uses, how they compare, and how choices differ between children and adults.
Psychostimulant Medications (First-Line)
Psychostimulants are the first-line treatment for ADHD in Australia for both children and adults, according to current clinical practice. They work quickly, are generally well studied, and fall into two chemical families: methylphenidate-based and amphetamine-based medications.
Methylphenidate-Based Medications
Methylphenidate is available in Australia under several brand names, each with a different release profile:
- Ritalin (immediate release): onset within 20 to 30 minutes, lasting around 3 to 4 hours. Often taken multiple times a day.
- Ritalin LA (long-acting): a biphasic release formulation lasting around 8 hours from a single morning dose.
- Concerta (extended release, osmotic delivery): onset within 1 to 2 hours, providing coverage for around 12 hours from a single morning dose.
Amphetamine-Based Medications
- Dexamphetamine: a short-acting tablet, with effects lasting roughly 4 to 6 hours per dose. Often taken two or three times a day.
- Vyvanse (lisdexamfetamine): a long-acting prodrug that is gradually converted to dexamfetamine in the body. It provides around 10 to 14 hours of symptom coverage from a single morning dose, with a smoother onset and offset than short-acting dexamphetamine.
List of ADHD medications for adults
Here’s a list of ADHD medications commonly prescribed for adults in Australia:
Medication | Type | Duration | Dosing Frequency |
|---|---|---|---|
Dexamphetamine | Amphetamine-based, short-acting | 4 to 6 hours | 2 to 3 times daily |
Vyvanse (lisdexamfetamine) | Amphetamine-based, long-acting | 10 to 14 hours | Once daily |
Ritalin (immediate release) | Methylphenidate-based, short-acting | 3 to 4 hours | 2 to 3 times daily |
Ritalin LA | Methylphenidate-based, long-acting | Around 8 hours | Once daily |
Concerta | Methylphenidate-based, extended release | Around 12 hours | Once daily |
Atomoxetine (Strattera) | Non-psychostimulant | All-day coverage, taken daily | Once or twice daily |
Guanfacine (Intuniv) | Non-psychostimulant | All-day coverage, taken daily | Once daily |
Duration and Onset at a Glance
Formulation Type | Onset | Typical Duration |
Short-acting (Ritalin IR, dexamphetamine) | 20 to 60 minutes | 3 to 6 hours |
Long-acting (Ritalin LA) | Within 1 to 2 hours | Around 8 hours |
Extended/very long-acting (Concerta, Vyvanse) | 1 to 2 hours | 10 to 14 hours |
Non-Psychostimulant Medications
Non-psychostimulants work differently to psychostimulants, generally take longer to reach full effect, and don’t carry the same misuse potential, since they aren’t classified as Schedule 8 controlled drugs in the same way amphetamine and methylphenidate medications are.
Atomoxetine (Strattera)
A selective noradrenaline reuptake inhibitor. Unlike psychostimulants, atomoxetine can take several weeks of consistent use to reach its full effect, and it’s taken daily rather than as needed. It’s an option for people who haven’t responded well to psychostimulants, can’t tolerate them, or have a history that makes a non-stimulant preferable.
Guanfacine (Intuniv)
An extended-release medication originally developed as a blood pressure treatment, now used in ADHD for its effects on attention and impulse regulation. It’s taken once daily and, like atomoxetine, builds up its effect gradually over time rather than working within the hour.
Clonidine
Another medication with origins in blood pressure treatment, sometimes used in ADHD management, particularly where sleep difficulties or tics are also present. It’s generally considered later in the treatment sequence rather than as an initial option.
When Non-Psychostimulants are Prescribed Instead of Stimulants
Non-psychostimulants are typically considered when:
- Psychostimulants haven’t been effective or caused unacceptable side effects
- There’s a personal or family history of substance use disorder, since non-psychostimulants carry a lower misuse potential
- A coexisting condition, such as significant anxiety or a tic disorder, makes a stimulant less suitable
- All-day, steady coverage without the peaks and troughs of a stimulant is preferred
Choosing the Right Medication
Most Effective ADHD Medication for Adults: What the Evidence Shows
Across the available evidence, psychostimulants (both methylphenidate-based and amphetamine-based medications) are consistently found to be more effective than non-psychostimulants at reducing core ADHD symptoms in adults.
Within the psychostimulant category, amphetamine-based medications such as dexamphetamine and lisdexamfetamine tend to show a slightly larger effect in adults than methylphenidate-based options in comparative research, although individual response varies considerably from person to person.
This is why medication choice in practice usually involves some trial and adjustment under a prescriber’s guidance, rather than a single medication being “best” for everyone.
Best ADHD Medication for Adults with Anxiety
For adults who have ADHD alongside significant anxiety, prescribers often approach psychostimulants more cautiously, since stimulants can increase feelings of anxiety or jitteriness in some people. In these cases, a non-psychostimulant such as atomoxetine or guanfacine is sometimes considered first, or a lower stimulant dose is used with closer monitoring.
This isn’t a fixed rule: many people with both ADHD and anxiety tolerate psychostimulants well, and effectively treating the underlying ADHD can sometimes reduce anxiety symptoms that stem from it. The right choice depends on the individual and is a decision made together with a prescriber, not a one-size-fits-all answer.
Kids vs. Adults: How Medication Choice Differs by Age
The same broad medication types are used in children and adults, but there are differences in how they’re approached:
- Children typically start at lower, weight-based doses, with regular monitoring of height, weight, heart rate, and blood pressure.
- Common ADHD medication names for children in Australia include Ritalin, Concerta, Vyvanse, dexamphetamine, and, less commonly, Strattera (atomoxetine) or Intuniv (guanfacine).
- Long-acting formulations are often preferred for school-aged children to avoid the need for a midday dose at school.
- In adults, dosing is less strictly weight-based, and there’s more variation in which formulation is chosen based on lifestyle, work schedule, and any coexisting conditions.
- PBS access rules also differ: for several adult ADHD medications, government-subsidised access depends on whether the condition can be shown to have started in childhood, even if the formal diagnosis happens later in life.
Common Side Effects by Medication Type
Side effects vary by medication type and by individual. For a full breakdown of what to expect and how side effects are typically managed, read our full guide to ADHD medication side effects.
Dexamphetamine Side Effects
Dexamphetamine’s side effect profile is broadly consistent with other amphetamine-based stimulants and commonly includes:
- Decreased appetite and, in some cases, weight loss
- Insomnia or difficulty settling to sleep, particularly if taken later in the day
- Increased heart rate and mild increases in blood pressure
- Headache, dizziness, or dry mouth
- Mood changes, irritability, or increased anxiety in some people
- Less commonly, palpitations or more pronounced cardiovascular effects, which is why heart rate and blood pressure are usually monitored during treatment
Most side effects are described as mild and more likely to occur in the first few days of treatment, often easing as the body adjusts. Any side effect that’s severe, persistent, or concerning should be discussed with the prescribing doctor rather than managed alone.
Stopping or Changing ADHD Medication
How Hard is it to get off ADHD meds?
Because ADHD medications, particularly the Schedule 8 psychostimulants, affect the brain’s dopamine and noradrenaline systems, stopping or changing them isn’t something to do abruptly or without medical guidance.
How straightforward or difficult this process feels varies from person to person and depends on factors like the specific medication, how long it’s been used, and individual physiology. Any decision to stop or change ADHD medication should always be made together with the prescribing doctor, who can guide the process safely and monitor for any return of symptoms or other effects.
Frequently Asked Questions
What are the top 3 ADHD medications?
In Australia, the ADHD medications prescribed most often are lisdexamfetamine (Vyvanse), methylphenidate in its extended-release form (Concerta), and dexamphetamine, reflecting their status as first-line psychostimulant options with strong evidence behind them.
What ADHD medication is used in Australia?
Australia uses both psychostimulant and non-psychostimulant ADHD medications. Psychostimulants include methylphenidate (Ritalin, Ritalin LA, Concerta) and amphetamine-based options (dexamphetamine, Vyvanse). Non-psychostimulants include atomoxetine (Strattera), guanfacine (Intuniv), and clonidine.
How hard is it to get off ADHD meds?
This varies by individual and medication, and should always be managed through a prescriber rather than attempted independently, given the way these medications interact with the brain’s chemistry.
What are the potential side effects of dexamphetamine?
Common side effects include decreased appetite, insomnia, increased heart rate, headache, dizziness, dry mouth, and mood changes or irritability. Most are mild and more noticeable early in treatment, though any severe or persistent effect should be raised with a doctor.
Conclusion
Medication decisions like these are made with a prescribing doctor, typically a GP working alongside a psychiatrist, who can weigh up formulation, dosing, and any coexisting conditions for your specific situation.
Services such as HelloDoc, an Australian telehealth psychiatry provider, are one option for accessing that kind of ADHD-focused clinical review.
HelloDoc (Disclaimer and Liability Terms)
HelloDoc aims to connect users with psychiatry professionals. However, we do not guarantee the accuracy, reliability, or completeness of the information shared. The platform does not warrant any professional medical advice, diagnosis, or treatment. All services are offered “as-is,” and users must assess their relevance independently.
HelloDoc is NOT an emergency response platform. All consultations are by appointment only. If you are experiencing a mental health crisis, please seek immediate assistance from emergency services.
For Mental Health Emergencies in Australia, contact:
- Lifeline: 13 11 14
- Beyond Blue: 1300 224 636
- MensLine Australia: 1300 789 978
- Suicide Call Back Service: 1300 659 467
- Veterans and Veterans Families Counselling Service: 1800 011 046
The information on this website, including blog posts, is for general informational purposes only and is not meant to replace or substitute for professional medical advice, diagnosis, or evidence-based treatment. Always consult a qualified healthcare provider for any medical condition or health-related questions. By continuing to use HelloDoc, you accept these terms and acknowledge that they may change without notice.
